{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T14:02:09Z","timestamp":1791468129434,"version":"4.3.4"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2020R1A5A2019210"],"award-info":[{"award-number":["NRF-2020R1A5A2019210"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.intimp.2026.117478","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:47:19Z","timestamp":1790855239000},"page":"117478","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The ALK inhibitor lorlatinib attenuates lipopolysaccharide-induced neuroinflammation by inhibiting microglial activation and preserving blood\u2013brain barrier integrity"],"prefix":"10.1016","volume":"190","author":[{"given":"Seong-Eun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do-Yeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Eun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yea-Hyun","family":"Leem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Sun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee-Sun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2026.117478_bb0005","doi-asserted-by":"crossref","unstructured":"Adamu, S. Li, F. Gao, G. Xue, The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets, Front. Aging Neurosci. 16 (2024) 1347987.","DOI":"10.3389\/fnagi.2024.1347987"},{"issue":"6753","key":"10.1016\/j.intimp.2026.117478_bb0010","doi-asserted-by":"crossref","DOI":"10.1126\/science.adx0043","article-title":"Neuroinflammation across neurological diseases","volume":"388","author":"Shi","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.intimp.2026.117478_bb0015","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.742065","article-title":"Microglia in neuroinflammation and neurodegeneration: from Understanding to Therapy","volume":"15","author":"Muzio","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.intimp.2026.117478_bb0020","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-021-02309-6","article-title":"The semantics of microglia activation: neuroinflammation, homeostasis, and stress","volume":"18","author":"Woodburn","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.intimp.2026.117478_bb0025","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1172\/JCI58644","article-title":"Innate immunity in the central nervous system","volume":"122","author":"Ransohoff","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2026.117478_bb0030","article-title":"Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets","volume":"8","author":"Gao","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2026.117478_bb0035","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a020412","article-title":"The blood-brain barrier","volume":"7","author":"Daneman","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.intimp.2026.117478_bb0040","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-13812-z","article-title":"Dual microglia effects on blood brain barrier permeability induced by systemic inflammation","volume":"10","author":"Haruwaka","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.117478_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2024.1360195","article-title":"Microglia at the blood brain barrier in health and disease","volume":"18","author":"Mayer","year":"2024","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.intimp.2026.117478_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2014.00362","article-title":"The impact of microglial activation on blood-brain barrier in brain diseases","volume":"8","author":"da Fonseca","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.intimp.2026.117478_bb0055","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.phrs.2012.11.007","article-title":"Anaplastic lymphoma kinase (ALK): structure, oncogenic activation, and pharmacological inhibition","volume":"68","author":"Roskoski","year":"2013","journal-title":"Pharmacol. Res."},{"issue":"Suppl. 3","key":"10.1016\/j.intimp.2026.117478_bb0060","doi-asserted-by":"crossref","first-page":"iii4","DOI":"10.1093\/annonc\/mdw301","article-title":"The role of the ALK receptor in cancer biology","volume":"27","author":"Hallberg","year":"2016","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.intimp.2026.117478_bb0065","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc2291","article-title":"The anaplastic lymphoma kinase in the pathogenesis of cancer","volume":"8","author":"Chiarle","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.intimp.2026.117478_bb0070","article-title":"Emerging roles of ALK in immunity and insights for immunotherapy","volume":"12","author":"Wang","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.intimp.2026.117478_bb0075","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan5689","article-title":"ALK is a therapeutic target for lethal sepsis","volume":"9","author":"Zeng","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.intimp.2026.117478_bb0080","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.neuron.2023.10.014","article-title":"STING signaling in the brain: molecular threats, signaling activities, and therapeutic challenges","volume":"112","author":"Yang","year":"2024","journal-title":"Neuron"},{"key":"10.1016\/j.intimp.2026.117478_bb0085","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/STROKEAHA.123.045991","article-title":"Inhibition of anaplastic lymphoma kinase protects from ischemic stroke","volume":"55","author":"Hu","year":"2024","journal-title":"Stroke"},{"key":"10.1016\/j.intimp.2026.117478_bb0090","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s40265-018-1041-0","article-title":"Lorlatinib: first global approval","volume":"79","author":"Syed","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.intimp.2026.117478_bb0095","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ejmech.2017.04.032","article-title":"First macrocyclic 3rd-generation ALK inhibitor for treatment of ALK\/ROS1 cancer: clinical and designing strategy update of lorlatinib","volume":"134","author":"Basit","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.intimp.2026.117478_bb0100","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/S1470-2045(18)30649-1","article-title":"Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 study","volume":"19","author":"Solomon","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.intimp.2026.117478_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1007315","article-title":"Therapeutic drug repositioning with special emphasis on neurodegenerative diseases: threats and issues","volume":"13","author":"Kakoti","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2026.117478_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2026.119596","article-title":"Lorlatinib protects dopaminergic neurons by inhibiting ALK-mediated neuroinflammation in a mouse model of Parkinson\u2019s disease","volume":"200","author":"Kim","year":"2026","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2026.117478_bb0115","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jneuroim.2009.01.020","article-title":"Anti-inflammatory mechanism of ginseng saponins in activated microglia","volume":"209","author":"Park","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.intimp.2026.117478_bb0120","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1586\/14737140.2016.1131612","article-title":"Overcoming crizotinib resistance in ALK-rearranged NSCLC with the second-generation ALK-inhibitor ceritinib","volume":"16","author":"Muller","year":"2016","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.intimp.2026.117478_bb0125","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.tcb.2022.11.001","article-title":"Cellular functions of cGAS-STING signaling","volume":"33","author":"Chen","year":"2023","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.intimp.2026.117478_bb0130","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1089\/ars.2012.5149","article-title":"Reactive oxygen species in inflammation and tissue injury","volume":"20","author":"Mittal","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.intimp.2026.117478_bb0135","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.pneurobio.2012.09.003","article-title":"Emerging roles of Nrf2 and phase II antioxidant enzymes in neuroprotection","volume":"100","author":"Zhang","year":"2013","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.intimp.2026.117478_bb0140","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/978-3-7091-6346-7_14","article-title":"Biological functions of extravasated serum IgG in rat brain","volume":"76","author":"Kadota","year":"2000","journal-title":"Acta Neurochir. Suppl."},{"key":"10.1016\/j.intimp.2026.117478_bb0145","article-title":"The role of STING signaling in central nervous system infection and neuroinflammatory disease","volume":"15","author":"Fritsch","year":"2023","journal-title":"WIREs Mech. Dis."},{"key":"10.1016\/j.intimp.2026.117478_bb0150","article-title":"Type I interferon response is mediated by NLRX1-cGAS-STING signaling in brain injury","volume":"15","author":"Fritsch","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.intimp.2026.117478_bb0155","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.tins.2020.10.008","article-title":"Signaling by cGAS-STING in neurodegeneration, neuroinflammation, and aging","volume":"44","author":"Paul","year":"2021","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.intimp.2026.117478_bb0160","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/s12974-018-1354-7","article-title":"STING-mediated type-I interferons contribute to the neuroinflammatory process and detrimental effects following traumatic brain injury","volume":"15","author":"Abdullah","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.intimp.2026.117478_bb0165","doi-asserted-by":"crossref","first-page":"17845","DOI":"10.1021\/acsnano.3c03390","volume":"17","author":"Sun","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.intimp.2026.117478_bb0170","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1038\/s12276-024-01295-y","article-title":"Blockade of STING activation alleviates microglial dysfunction and a broad spectrum of Alzheimer's disease pathologies","volume":"56","author":"Chung","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.intimp.2026.117478_bb0175","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2118819119","article-title":"STING mediates neurodegeneration and neuroinflammation in nigrostriatal a-synucleinopathy","volume":"119","author":"Hinkle","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2026.117478_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2018.00114","article-title":"Effect of chronic oxidative stress on neuroinflammatory response mediated by CD4+ T cells in neurodegenerative diseases","volume":"12","author":"Solleiro-Villavicencio","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.intimp.2026.117478_bb0185","doi-asserted-by":"crossref","first-page":"15182","DOI":"10.3390\/ijms232315182","article-title":"The relationship between reactive oxygen species and the cGAS\/STING signaling pathway in the inflammaging process","volume":"23","author":"Andrade","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.117478_bb0190","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1038\/s41467-021-22572-8","article-title":"STING enhances cell death through regulation of reactive oxygen species and DNA damage","volume":"12","author":"Hayman","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.117478_bb0195","doi-asserted-by":"crossref","first-page":"7210","DOI":"10.2741\/3223","article-title":"Oxidative stress-induced disruption of epithelial and endothelial tight junctions","volume":"13","author":"Rao","year":"2008","journal-title":"Front. Biosci."},{"key":"10.1016\/j.intimp.2026.117478_bb0200","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/03008200802143166","article-title":"The role of reactive oxygen species in integrin and matrix metalloproteinase expression and function","volume":"49","author":"Svineng","year":"2008","journal-title":"Connect. Tissue Res."},{"key":"10.1016\/j.intimp.2026.117478_bb0205","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","article-title":"The blood-brain barrier: structure, regulation, and drug delivery","volume":"8","author":"Wu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2026.117478_bb0210","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/glia.10108","article-title":"Matrix metalloproteinases in neuroinflammation","volume":"39","author":"Rosenberg","year":"2002","journal-title":"Glia"},{"key":"10.1016\/j.intimp.2026.117478_bb0215","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3389\/fncel.2016.00056","article-title":"Implications of MMP9 for blood brain barrier disruption and hemorrhagic transformation following ischemic stroke","volume":"10","author":"Turner","year":"2016","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.intimp.2026.117478_bb0220","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12974-015-0434-1","article-title":"Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit","volume":"12","author":"Banks","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.intimp.2026.117478_bb0225","article-title":"Lipopolysaccharide-induced middle ear inflammation disrupts the cochlear intra-strial fluid-blood barrier through down-regulation of tight junction proteins","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2026.117478_bb0230","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1021\/jm500261q","volume":"57","author":"Johnson","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.intimp.2026.117478_bb0235","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1002\/jcph.2056","article-title":"Evaluation of lorlatinib cerebrospinal fluid concentrations in relation to target concentrations for anaplastic lymphoma kinase (ALK) inhibition","volume":"62","author":"Sun","year":"2022","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.intimp.2026.117478_bb0240","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11523-020-00702-4","article-title":"Brain penetration of lorlatinib: cumulative incidences of CNS and non-CNS progression with lorlatinib in patients with previously treated ALK-positive non-small-cell lung cancer","volume":"15","author":"Bauer","year":"2020","journal-title":"Target. Oncol."},{"key":"10.1016\/j.intimp.2026.117478_bb0245","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1021\/jm501535r","article-title":"CNS drug design: balancing physicochemical properties for optimal brain exposure","volume":"58","author":"Rankovic","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.intimp.2026.117478_bb0250","doi-asserted-by":"crossref","first-page":"9627","DOI":"10.2147\/DDDT.S565228","article-title":"Cyp3a4-mediated in vitro metabolism and in vivo disposition of lorlatinib in rats","volume":"19","author":"Xie","year":"2025","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.intimp.2026.117478_bb0255","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ebiom.2019.01.019","article-title":"Prediction of ALK mutations mediating ALK-TKIs resistance and drug re-purposing to overcome the resistance","volume":"41","author":"Okada","year":"2019","journal-title":"EBioMedicine"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926013251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926013251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:26:38Z","timestamp":1791465998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926013251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":51,"alternative-id":["S1567576926013251"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117478","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The ALK inhibitor lorlatinib attenuates lipopolysaccharide-induced neuroinflammation by inhibiting microglial activation and preserving blood\u2013brain barrier integrity","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117478","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117478"}}